Jane Street Group, LLC Galera Therapeutics, Inc. Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.09 - $0.27 $1,026 - $3,080
11,410 New
11,410 $1,000
Q2 2023

Aug 14, 2023
SELL
$2.5 - $3.42 $13,540 - $18,522
-5,416 Reduced 27.28%
14,437 $45,000
Q1 2023

May 15, 2023
BUY
$1.48 - $2.68 $13,986 - $25,326
9,450 Added 90.84%
19,853 $50,000
Q4 2022

Feb 14, 2023
BUY
$1.34 - $1.78 $13,940 - $18,517
10,403 New
10,403 $15,000

Others Institutions Holding GRTX

# of Institutions
2
Shares Held
909K
Call Options Held
0
Put Options Held
0
View Full List

About Galera Therapeutics, Inc.

GRTX Quotes by TradingView
  • Ticker GRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,821,600
  • Market Cap $1.07M
  • Description
  • Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...
More about GRTX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email